Developing relationships with medicine regulators in China and India is just one of the challenges facing Emer Cooke, the international face of the European Medicines Agency (EMA), Scrip's Elizabeth Sukkar finds.
The first time I heard
Emer ...
As Allon Therapeutics prepares to advance its lead drug candidate, davunetide intranasal (formerly AL-108), into proof-of-concept trials for progressive supranuclear palsy (PSP), its chief medical officer,
Dr Steven Whitaker
told Scrip of the ...
At last year's Bio-Europe Spring conference, Trophos 's CEO Dr
Damian Marron
told Scrip that the French company had high hopes for its lead product TRO19622 (olesoxime) in amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy. Nine months ...
Many pharmaceutical and biotech companies devote themselves to the discovery and development of novel drugs for unmet medical needs. However, with R&D costs and regulatory hurdles multiplying, and much of the low-hanging therapeutic fruit already ...
